Card image cap

Gregg Harper's Public Statements

Page 1 of 10

Date Title
11/30/2018 Letter to the Hon. Alex Azar, Secretary of Health and Human Services - Lawmakers Advocate for Pro-Life Principles on Fetal Tissue
11/27/2018 Letter to the Hon. Scott Gottlieb, Comissioner of the Food and Drug Administration - Lawmakers Urges FDA to Label Sesame Products
09/27/2018 Letter to the Hon. Mike Pompeo, Secretary of State - Efforts to Halt Trafficking of Deadly Fentanyl
09/27/2018 Letter to the Hon. Kirstjen Nielsen, Secretary of Homeland Security - Efforts to Halt Trafficking of Deadly Fentanyl
09/27/2018 Letter to the Hon. Scott Gottlieb, Department of Health and Human Services Commissioner of Food and Drugs - Concerns Regarding the Office of Laboratory Science and Safety
09/27/2018 Letter to Uttam Dhillon, Acting Director of the Drug Enforcement Administration - Efforts to Halt Trafficking of Deadly Fentanyl
09/20/2018 Letter to Seema Verma, Administrator of the Centers for Medicare and Medicaid Services - 214 Members of the Bipartisan Diabetes Caucus Work to Increase Access for Artificial Pancreas Systems
09/17/2018 Letter to Dr. Scott Gottlieb, Commissioner of the Food and Drug Administration - Abraham: HHS Right to Cancel Fetal Tissue Contract
08/30/2018 Letter to Pharmacy Benefit Mangers of CVS, EnvisionRXOptions, Express Scripts Holding Company, Humana Inc., Prime Therapeutics, Procare Pharmacy Benefit Manager, Inc., and UnitedHealth Group - Regarding their Role in the Drug Supply Chain
08/30/2018 Letter to Francis Crosson, MD, Chairman of the Medicare Payment Advisory Commission - Examine Cost Drivers of Health Care
08/27/2018 Letter to the Hon. Kirstjen Nielsen, Secretary of Homeland Security - Common Vulnerabilities Exposures (CVE) Program Recommendations
08/27/2018 Letter to Dr. Jason Providakes, President and CEO of MITRE Corporation - Common Vulnerabilities Exposures (CVE) Program Recommendations
08/02/2018 Letter to Saeed Motahari, President and Chief Executive Officer of Insys Therapeutics - Letters Continue Committee's Comprehensive Review of Opioid Epidemic
08/02/2018 Letter to Mark Trudeau, President and Chief Executive Officer of Mallinckrodt Pharmaceuticals - Greg Walden Presses Opioid Manufacturers About Their Role in Crisis
08/02/2018 Letter to Craig Landau, President and Chief Executive Officer of Purdue Pharma - Letters Continue Committee's Comprehensive Review of Opioid Epidemic
08/01/2018 Letter to Nine Contract Pharmacies that Participate in the 340B Drug Pricing Program - Letters Follow Report from Nonpartisan Watchdog & #SubHealth Hearing
07/27/2018 Letter to the Hon. Joseph Simons, Chairman of the Federal Trade Commission - E&C Leaders Request FTC Review PBM Mergers
07/23/2018 Letter to the Honorable Ajit Pai, Chairman for the Federal Communications Commission - Committee Seeks Update On 9-1-1 Fee Diversion
07/18/2018 Letter to John Duffy, Chief Executive Officer of 3Cinteractice Corporation - Cmte Leaders Probe LocationSmart, Third-Parties on Location Sharing Practices
07/18/2018 Letter to Mario Proietti, Chief Executive Officer of LocationSmart - Cmte Leaders Probe LocationSmart, Third-Parties on Location Sharing Practices
07/18/2018 Letter to Robert Pickens, Chief Executive Officer of Securus Technologies - Cmte Leaders Probe LocationSmart, Third-Parties on Location Sharing Practices
07/13/2018 Letter to the Hon. Andrew Wheeler, Acting Administrator of the Environmental Protection Agency - Letter to Acting EPA Administrator Andrew Wheeler Regarding EPA Grant Management Practices
07/09/2018 Letter to Tim Cook, CEO of Apple Inc. - Third-Party Access, Audio and Location Data Collection
07/09/2018 Letter to Larry Page, CEO of Alaphabet, Inc. - Third-Party Access, Audio and Location Data Collection
07/03/2018 Letter to the Hon. Scott Pruitt, EPA Administrator - Management of Contractors

Page 1 of 10
arrow_upward